treatment group:Nil

3 trials

Sponsors

Xi'an First Hospital, Cangzhou Central Hospital, Shanghai Jiaotong University School of Medicine Ruijin-Hainan Hospital (Hainan Boao Research Hospital)

Conditions

Gastric Cancerneurotrophic keratitis (NK)relapsed and/or refractory multiple myeloma

Early Phase 1

A prospective clinical study of PD-1 inhibitor combined with albumin-paclitaxel + oxaliplatin + S-1 chemotherapy for perioperative treatment of locally advanced gastric cancer

RecruitingChiCTR2200055659

Cangzhou Central HospitalGastric Cancer

Start: 2022-01-16Updated: 2023-06-26

Phase 4

clinical efficacy evaluation about recombinant human nerve growth factor on neurotrophic keratitis

RecruitingChiCTR2100053592

Xi'an First Hospitalneurotrophic keratitis (NK)

Start: 2021-12-01Updated: 2022-10-17

Unknown Phase

A single-arm, multi-center, observational, and prospective study in Chinese relapsed and/or refractory multiple myeloma patients treated with isatuximab in combination with pomalidomide and dexamethasone

RecruitingChiCTR2200062878

Shanghai Jiaotong University School of Medicine Ruijin-Hainan Hospital (Hainan Boao Research Hospital)relapsed and/or refractory multiple myeloma

Start: 2022-09-13Updated: 2023-07-30

Related Papers

Real-world outcomes of isatuximab with pomalidomide and dexamethasone for relapsed and/or refractory multiple myeloma

Chinese Medical Journal2025-05-291 citations